B2i Digital Named Marketing Partner for 15th Annual ROTH London Conference
NEW YORK, NY - May 18, 2025 (NEWMEDIAWIRE) - B2i Digital, Inc. will once again serve as the marketing partner for the 15th Annual ROTH London Conference, an exclusive, invite-only event connecting executive management from approximately 70 companies with institutional investors. The conference will be held June 2426, 2025, at the Four Seasons Hotel London at Park Lane.
ROTH's London Conference offers 1-on-1 and small group meetings between company leaders and investors across a range of sectors. These 40-minute sessions are designed to provide deeper insight into each company's business model, growth strategy, and long-term vision. The event also includes networking opportunities throughout the three-day schedule.
As the Marketing Partner, B2i Digital will publish profiles of the presenting companies on its platform, https://b2idigital.com/roth-15th-annual-london-conference and across 11 social media platforms. These profiles help participating companies reach retail, institutional and family office investors globally.
"B2i Digital is proud to support the ROTH London Conference again this year," said David Shapiro, CEO of B2i Digital. "We know that if a conference has the ROTH name on it, it will be a successful event with top-tier companies and fully vetted investors. This will be our final major event until fall, and we strongly encourage all investors who are able to attend."
Participation in the ROTH London Conference is by invitation only and subject to approval by ROTH. Investors interested in attending should contact their ROTH representative or request registration via the official site.
About B2i Digital, Inc.
B2i Digital, Inc. partners with a select group of public companies, investor conferences and essential capital markets advisors through its Featured Company, Featured Conference and Featured Expert programs. It leverages the latest digital marketing technologies, its network of 1.3 million investors and targeted introductions to bring together key players in the markets. B2i Digital was founded in 2021 by David Shapiro, previously an investment banker and Chief Marketing Officer at Maxim Group LLC and its investor awareness platform, M-Vest.com.
B2i Digital Contact Information:
David ShapiroChief Executive OfficerB2i Digital, Inc.https://b2idigital.com/212.579.4844 Officedavid@b2idigital.com
https://www.linkedin.com/in/davidshapironychttps://www.linkedin.com/company/b2i-digitalhttps://x.com/b2idigitalhttps://www.facebook.com/b2idigitalhttps://www.instagram.com/b2i_digitalhttps://www.youtube.com/@b2idigitalhttps://stocktwits.com/B2iDigitalhttps://www.reddit.com/user/b2idigital/https://www.pinterest.com/b2idigital/https://www.tiktok.com/@b2idigitalhttps://www.threads.net/@b2i_digitalhttps://bsky.app/profile/b2idigital.bsky.social
About ROTH Capital Partners, LLC
ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Our full-service platform provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately held, employee-owned organization and maintains offices throughout the U.S. For more information on ROTH MKM, please visit www.roth.com.
Investor Contact: ROTH MKMIsabel Mattson-PainManaging Director, Chief Marketing Officerimattson-pain@roth.comhttps://www.linkedin.com/company/rothcapitalpartners/https://www.roth.com
View the original release on www.newmediawire.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
38 minutes ago
- Business Wire
Knightscope Secures Another $1M in New Sales, Renewals & Expansions;
SUNNYVALE, Calif.--(BUSINESS WIRE)-- Knightscope, Inc. (NASDAQ: KSCP), a leader in developing autonomous security robots and artificial intelligence technologies, today announced over $1 million in newly secured contracts that span major client renewals, strategic expansions, and new wins across the country. The increase reflects a continuing demand for smarter, safer environments and is underscored by ongoing interest, including on Capitol Hill. Emergency Communication Devices Grow Across the Nation Knightscope locked in major new wins in the higher education, parks & recreation, healthcare, and local government sectors with an impressive 541 brand-new Emergency Communication Devices (ECDs) bookings. This wave of new contracts highlights the widespread trust in Knightscope's life-saving communication technology. Robots on Patrol: ASRs Hit New Markets Knightscope's Autonomous Security Robots (ASRs) are on the move. New K5 contracts are rolling out in the Transit Authority, Data Center, and Higher Education sectors, reinforcing its growing presence across critical infrastructure and public spaces. Highlights at a Glance Public Sector Power – Cities, states and law enforcement agencies are doubling down with expanded ECD purchases and extended Full-Service Maintenance (FSM) agreements. Renewals Signal Results – Eight (8) ASR subscriptions were renewed across key sectors, including retail, biotech, and hospitality, proving Knightscope's staying power and performance. Capitol Hill Knightscope continues to gain meaningful traction in Washington, D.C. Following recent visits that included dozens of engagements with public officials and stakeholders, the Company has been invited back for a hearing on certain technologies to occur in July. About Knightscope Knightscope is transforming public safety with cutting-edge robotics and AI technologies. From autonomous security robots to advanced detection systems, Knightscope is committed to building safer communities where you live, work, study and visit. Our long-term ambition is bold but simple: to make the United States of America the safest country in the world. Learn more about us at Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," "proposes" and similar expressions. Forward-looking statements contained in this press release and other communications include, but are not limited to, statements about the Company's goals, profitability, growth, prospects, reduction of expenses, and outlook. Although Knightscope believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks, uncertainties and other important factors that could cause actual results to differ materially from such forward-looking statements, including the factors discussed under the heading "Risk Factors" in Knightscope's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of the document in which they are contained, and Knightscope does not undertake any duty to update any forward-looking statements, except as may be required by law.
Yahoo
42 minutes ago
- Yahoo
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
PEACHTREE CORNERS, Ga., July 02, 2025--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on June 27th that it made its first shipment of devices and single use components to Hangzhou Dongye Medical Technology Company, Ltd. (HDMT). This order is in addition to future shipments connected with a separate $700,000 purchase order executed earlier this year between HDMT and GTHP. Based on the June 27th shipment, GTHP will recognize an additional $117,462 in sales revenue for the second quarter of 2025. The first three devices from the new $700,000 order have been manufactured and tested, triggering a $70,000 payment from HDMT expected in July 2025. HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive provider of gynecology products for 42 hospitals that perform approximately two million cervical cancer screenings annually. About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading "Risk Factors" in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent filings. View source version on Contacts Mark FaupelGuided Therapeutics770-242-8723 Sign in to access your portfolio
Yahoo
42 minutes ago
- Yahoo
VB Attorneys Obtains $4,000,000 Verdict on Behalf of Injured Seaman
HOUSTON, July 02, 2025--(BUSINESS WIRE)--Vuk Vujasinovic and Job Tennant of VB Attorneys obtained a $4,000,000 jury verdict on behalf of an employee of Phoenix Processor who was injured aboard the ship M/V Excellence during commercial fishing operations in the Bering Sea. This Jones Act case was filed and tried in state court in King County, Washington. The jury returned its verdict on June 16, 2025. The company's highest offer before trial was $600,000. The employee, who worked as a Processor, was injured in the factory of the ship when a pan full of frozen fish fell onto the big toe of his left foot, causing it to fracture and dislocate. Despite the employee's requests to be brought to land for medical treatment, Phoenix Processor made him stay on its ship for 9 days until it completed fishing operations and returned to port in Dutch Harbor, Alaska. The company's Claims Manager caused further delays in failing her responsibility to get the injured employee proper and timely medical care per the company's legal obligation to provide maintenance and cure. The employee underwent several surgeries to his toe and foot, and was diagnosed with Complex Regional Pain Syndrome. To support the case, VB Attorneys retained experts in the fields of marine operations, biomechanics, and life care planning. Claims for past and future lost wages and earnings were withdrawn before trial. Phoenix Processor denied any and all liability throughout the litigation. The jury found the negligence of Phoenix Processor caused the employee's injury. The jury awarded future medical costs and non-economic damages in the total amount of $4,000,000. The jury found the employee was 25% negligent in causing the injury, reducing the damages to $3,000,000. The jury found the employee is not at Maximum Medical Improvement, and therefore Phoenix Processor must continue paying maintenance and cure benefits. About VB AttorneysVB Attorneys is a nationally recognized trial law firm based in Houston, Texas. With a proven track record of securing substantial verdicts and settlements, the firm represents individuals and families in cases involving catastrophic personal injuries, maritime and offshore injuries, trucking and workplace accidents, and wrongful death. The attorneys at VB Attorneys are dedicated to fighting for justice and holding corporations accountable for negligence. Learn more at View source version on Contacts Vuk Vujasinovicvuk@ (888) 430-0906 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
